2491
Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate; the drug should be withdrawn immediately if abnormal liver function tests are found.
 patients: Subject; abnormal liver function: Effect; receiving high doses of cyproterone acetate: Treatment; cyproterone acetate: Treatment.Drug; high doses: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients: Subject; abnormal liver function: Effect; receiving high doses of cyproterone acetate: Treatment; cyproterone acetate: Treatment.Drug; high doses: Treatment.Dosage